Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4

Journal of Clinical Investigation

Volumn 110, Issue 6, 2002, Pages 751-759

  Peng, Hairong ^a,b   Wright, Vonda ^b   Usas, Arvydas ^a,b   Gearhart, Brian ^a   Shen, Hsain Chung ^b,c   Cummins, James ^a   Huard, Johnny ^a,b,d  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE REGENERATION; CELL SURVIVAL; CHONDROLYSIS; CONTROLLED STUDY; DRUG MECHANISM; GENE THERAPY; MALE; MESENCHYME; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STEM CELL;

EID: 0036738338     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI15153     Document Type: Article

References (30)

1. Musculoskeletal conditions in the United States
2. Bone formation by autoinduction
3. Novel regulators of bone formation: Molecular clones and activities
4. Purification and characterization of other distinct bone-inducing factors
5. The transforming growth factor beta family and induction of the vertebrate mesoderm: Bone morphogenetic proteins are ventral inducers
6. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes
7. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats
8. Gene therapy: Adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo
9. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector
10. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing
11. Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4
12. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: A novel cell-mediated gene therapy
13. Engineered human mesenchymal stem cells: A novel platform for skeletal cell mediated gene therapy
14. Exogenously regulated stem cell-mediated gene therapy for bone regeneration
15. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2
16. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
17. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells
18. VEGF gene delivery to muscle: Potential role for vasculogenesis in adults
19. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression
20. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression
21. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions
22. Vascular endothelial growth factor is a secreted angiogenic mitogen
23. Vascular permeability factor, an endothelial cell mitogen related to PDGF
24. Developmental control of blood cell migration by the Drosophila VEGF pathway
25. VEGF(165) promotes survival ofleukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition
26. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway
27. Cell proliferation and apoptosis during fracture healing
28. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
29. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts
30. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation